Skin Reaction to Cetuximab as Criteria for Treatment Selection in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Phase 2 Study.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- 11 Dec 2011 Actual initiation date (Dec 2011) added as reported by ClinicalTrials.gov.
- 11 Dec 2011 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 11 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.